New pilot program aims to ease diabetes distress in young patients

NCT ID NCT07116434

Recruiting now Symptom relief Sponsor: Vanderbilt University Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot trial tests the Discovery Program, a 3-month behavioral intervention for adolescents and young adults with type 1 diabetes. The program combines patient surveys, in-clinic goal setting, and personalized text messages to help improve blood sugar control and reduce diabetes-related stress. Researchers will compare participants in the program to those receiving standard care, tracking outcomes over 6 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Discovery Program (behavioral intervention combining patient-reported measures, in-clinic goal setting, and personalized mobile health communications)
What this could lead to: If it works, this could point toward a practical, low-cost way to help teens and young adults with type 1 diabetes improve their blood sugar control and feel less overwhelmed by their condition.
What could go wrong: This is a small pilot study with only 150 participants, so results may not apply to everyone. The program is behavioral, so its success depends on how well participants engage with it, and it may not lead to lasting changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 1 DIABETES

Contacts and locations

Locations

Vanderbilt University
RECRUITING

Nashville, Tennessee, 37240, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.